Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the complete record of transactions filed by Gladney Dan W, Executive. Insider active across 1 company, notably ReShape Lifesciences Inc.. Cumulatively, 1 disclosures have been recorded. History available since 22 July 2021. The latest transaction was filed on 22 July 2021 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration
Dan W. Gladney is a Director at ReShape Lifesciences Inc. He contributes to the governance of the company and strategic decision-making, bringing his expertise in the healthcare sector.